Biomarkers in Cardiorenal Syndrome

Giovanni Goffredo; Roberta Barone; Vito Di Terlizzi; Michele Correale; Natale Daniele Brunetti; Massimo Iacoviello

doi:10.3390/jcm10153433

Biomarkers in Cardiorenal Syndrome

J Clin Med. 2021 Jul 31;10(15):3433. doi: 10.3390/jcm10153433.

Authors

Giovanni Goffredo^{1

2}, Roberta Barone^{1

2}, Vito Di Terlizzi^{1

2}, Michele Correale^{1

2}, Natale Daniele Brunetti^{1

2}, Massimo Iacoviello^{1

2}

Affiliations

¹ Department of Medical and Surgical Sciences, University of Foggia, Viale Luigi Pinto 1, 71122 Foggia, Italy.
² Cardiology Unit, University Policlinic Hospital Riuniti, Viale Luigi Pinto 1, 71122 Foggia, Italy.

Abstract

Cardiorenal syndrome is a clinical manifestation of the bidirectional interaction between the heart and kidney diseases. Over the last years, in patients with cardiovascular diseases, several biomarkers have been studied in order to better assess renal function as well as to identify patients prone to experiencing chronic or acute worsening of renal function. The aim of this review is to focus on the possible clinical usefulness of the most recent biomarkers in the setting of cardiorenal syndrome.

Keywords: acute kidney injury; biomarkers; cardio-renal syndrome; heart failure; renal function.

Publication types

Review